Literature DB >> 17643064

Role of Glycoproteins Isolated from Epicoccum purpurascens in Host-Pathogen Interaction.

Neetu Kukreja1, Naveen Arora, Bhanu Pratap Singh, Hasi Rani Das, Susheela Sridhara.   

Abstract

OBJECTIVE: Attachment to host matrix is an important provisory step for the institution of any fungal infection. The present study investigates the role of glycoproteins of Epicoccum purpurascens in host-fungal adherence.
METHODS: Epicoccum spore-mycelial extract was fractionated on a concanavalin A-Sepharose column. Three glycoproteins of 12, 17 and 33 kDa (Epi p 1) were electroeluted and checked for hemagglutination and hemagglutination inhibition. The monosaccharide content of the highly potent protein Epi p 1 was determined by high-performance anion exchange chromatography and pulsed amperometric detection. The interaction of Epi p 1 with mannose-binding lectin (MBL) leading to the activation of the complement system was studied by immunoblot, ELISA and ELISA inhibition techniques. Immunoblot and immunoblot inhibition were carried out with culture filtrate to determine the nature of Epi p 1.
RESULTS: 33 (Epi p 1)-, 17- and 12-kDa proteins were 58, 46 and 38 times more potent than crude extract in hemagglutination activity (HA). The HA of Epi p 1 was inhibited by N-acetyl glucosamine, glucose and laminin. Epi p 1 had a high mannose content, showed MBL binding in ion-dependent manner and caused complement activation. The protein was detected in culture filtrate and thus seems to play a significant role in fungal invasion.
CONCLUSION: Epi p 1, an allergenic glycoprotein of E. purpurascens, is involved in host-fungal interactions through MBL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643064     DOI: 10.1159/000103378

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  1 in total

1.  Effect of proteolytic activity of Epicoccum purpurascens major allergen, Epi p 1 in allergic inflammation.

Authors:  N Kukreja; S Sridhara; B P Singh; N Arora
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.